Medtronic 2008 Annual Report Download - page 56

Download and view the complete annual report

Please find page 56 of the 2008 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 98

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98

(in millions)
Common
Shares
Common
Stock
Retained
Earnings
Accumulated
Other
Comprehensive
(Loss)/Income
Total
Shareholders’
Equity
Balance April 30, 2005 1,210 $ 121 $ 10,179 $ 150 $ 10,450
Net earnings 2,547 2,547
Other comprehensive (loss)/income
Unrealized gain on investments 1 1
Translation adjustment — — (13) (13)
Minimum pension liability (9) (9)
Unrealized gain on foreign exchange derivatives 26 26
Total comprehensive income 2,552
Dividends to shareholders (465) (465)
Issuance of common stock under stock purchase and award plans 14 2 516 518
Repurchase of common stock (69) (7) (3,582) (3,589)
Excess tax benefit from exercise of stock-based awards 99 99
Purchased call options, net of tax benefit (699) (699)
Sale of warrants 517 517
Balance April 28, 2006 1,155 $ 116 $ 9,112 $ 155 $ 9,383
Net earnings 2,802 2,802
Other comprehensive (loss)/income
Unrealized gain on investments 20 20
Translation adjustment — — 18 18
Minimum pension liability 24 24
Unrealized loss on foreign exchange derivatives (70) (70)
Total comprehensive income 2,794
Dividends to shareholders (504) (504)
Issuance of common stock under stock purchase and award plans 10 1 330 331
Adjustment to adopt SFAS No. 158 (Note 1) (209) (209)
Repurchase of common stock (22) (3) (1,036) (1,039)
Excess tax benefit from exercise of stock-based awards 36 36
Stock-based compensation 185 185
Balance April 27, 2007 1,143 $ 114 $ 10,925 $ (62) $ 10,977
Net earnings — 2,231 2,231
Other comprehensive (loss)/income
Unrealized loss on investments — — (47) (47)
Translation adjustment — — 14 14
Net change in retirement obligations — — 37 37
Unrealized loss on foreign exchange derivatives — (211) (211)
Total comprehensive income 2,024
Dividends to shareholders — (565) (565)
Issuance of common stock under stock purchase and award plans 13 1 402 403
Adjustment to deferred tax benefit recorded on adoption of SFAS No. 158 — — (17) (17)
Repurchase of common stock (31) (3) (1,541) (1,544)
Excess tax benefit from exercise of stock-based awards — — 40 40
Stock-based compensation — — 217 217
Cumulative effect adjustment to retained earnings related to the adoption
of FIN No. 48 (Note 12) — — 1 1
Balance April 25, 2008
1,125
$ 112
$ 11,710
$ (286
)
$ 11,536
The accompanying notes are an integral part of these consolidated financial statements.
Consolidated Statements of Shareholders’ Equity
52 Medtronic, Inc.